Workshop on partial breast irradiation: State of the art and the science, Bethesda, MD, December 8-10, 2002 Journal Article


Authors: Wallner, P.; Arthur, D.; Bartelink, H.; Connolly, J.; Edmundson, G.; Guiliano, A.; Goldstein, N.; Hevezi, J.; Julian, T.; Kuske, R.; Lichter, A.; McCormick, B.; Orecchia, R.; Pierce, L.; Powell, S.; Solin, L.; Vicini, F.; Whelan, T.; Wong, J.; Coleman, N. C.
Article Title: Workshop on partial breast irradiation: State of the art and the science, Bethesda, MD, December 8-10, 2002
Abstract: Breast conserving surgery followed by radiation therapy has been accepted as an alternative to mastectomy in the management of patients with early-stage breast cancer. Over the past decade there has been increasing interest in a variety of radiation techniques designed to treat only the portion of the breast deemed to be at high risk for local recurrence (partial-breast irradiation [PBI]) and to shorten the duration of treatment (accelerated partial-breast irradiation [APBI]). To consider issues regarding the equivalency of the various radiation therapy approaches and to address future needs for research, quality assurance, and training, the National Cancer Institute, Division of Cancer Treatment and Diagnosis, Radiation Research Program, hosted a Workshop on PBI in December 2002. Although 5- to 7-year outcome data on patients treated with PBI and APBI are now becoming available, many issues remain unresolved, including clinical and pathologic selection criteria, radiation dose and fractionation and how they relate to the standard fractionation for whole breast irradiation, appropriate target volume, local control within the untreated ipsilateral breast tissue, and overall survival. This Workshop report defines the issues in relation to PBI and APBI, recommends parameters for consideration in clinical trials and for reporting of results, serves to enhance dialogue among the advocates of the various radiation techniques, and emphasizes the importance of education and training in regard to results of PBI and APBI as they become emerging clinical treatments. © Oxford University Press 2004, all rights reserved.
Keywords: cancer survival; treatment outcome; clinical trial; cancer recurrence; cancer risk; patient selection; united states; radiotherapy, adjuvant; cancer staging; quality control; breast cancer; mastectomy; tumor volume; radiotherapy dosage; radiotherapy; breast neoplasms; cancer research; europe; cancer center; training; education; randomized controlled trials; radiation dose fractionation; conservative treatment; brachytherapy; intermethod comparison; radiotherapy planning, computer-assisted; canada; mastectomy, segmental; workshop; oncological parameters; clinical trials, phase iii; humans; human; female; priority journal; article
Journal Title: JNCI: Journal of the National Cancer Institute
Volume: 96
Issue: 3
ISSN: 0027-8874
Publisher: Oxford University Press  
Date Published: 2004-02-04
Start Page: 175
End Page: 184
Language: English
PROVIDER: scopus
PUBMED: 14759984
DOI: 10.1093/jnci/djh023
DOI/URL:
Notes: J. Natl. Cancer Inst. -- Cited By (since 1996):55 -- Export Date: 16 June 2014 -- CODEN: JNCIA C2 - 14759984 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Beryl McCormick
    371 McCormick